Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
نویسندگان
چکیده
Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pulmonary symptoms are also known to develop from taking this drug. There have been no reports about lansoprazole-induced interstitial lung disease. We report here a case of lansoprazole-induced interstitial lung disease that developed in a 66-year-old man.
منابع مشابه
گزارش یک مورد نارسایی حاد کلیه به دنبال اندوکاردیت عفونی
Introduction: Prevalence of infective endocarditic induced renal failure is 1-3% and is one of the causes of deterioration of patient or cessation of antibiotic therapy and also delay in treatment duration and medical response. Case Report: Our patient is a 48 year old man with infective endocarditis who had been under treatment by antibiotics (cefteriaxone, gentamycin and vencomycin) and exp...
متن کاملSulfasalazine-induced pulmonary disease.
We report the findings in two patients with sulfasalazine-induced pulmonary disease. The first patient developed pulmonary interstitial fibrosis after more than 4 yr of treatment for Crohn's disease. Pulmonary symptoms and chest roentgenographic and pulmonary function abnormalities gradually reversed after stopping the drug. No specific treatment was given. The second patient, who had rheumatoi...
متن کاملPleuropulmonary changes induced by ergoline drugs.
Classic ergolines, such as bromocriptine, methysergide and ergotamine, can induce chronic pleuropneumonitis. We present the cases of eight patients who developed similar changes whilst on other ergolines. In this retrospective case study spanning 1985-1995, clinical data, radiological material, pulmonary function, bronchoalveolar lavage and histopathology were reviewed. Earlier literature on er...
متن کاملElevation of serum thioredoxin in patients with gefitinib-induced interstitial lung disease.
OBJECTIVE Interstitial lung disease (ILD) is a severe adverse event of gefitinib therapy. However, the mechanism still remains unclear. The objective of this study was to examine whether or not oxidative stress, one of the common factors in drug-associated ILD, is involved in the pathogenesis of gefitinib-induced ILD. PATIENTS AND METHODS Using an enzyme-linked immunosorbent assay (ELISA), we...
متن کاملDrug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit.
BACKGROUND Acute tubulo-interstitial nephritis (TIN) is an important cause of acute renal failure, and is often caused by hypersensitivity to drugs. The aim of this study was to determine the aetiology of interstitial nephritis among an unselected cohort of patients, and to identify those drugs commonly implicated. METHODS A single-centre retrospective analysis was carried out of renal biopsy...
متن کامل